Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOBRA: Topical Antibiotic Therapy for Fracture Infection Prevention
NCT04597008Phase 3Completed
- Sponsor
- Major Extremity Trauma Research Consortium
- Start
- Jun 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tobramycin in surgical site infection (SSI), sponsored by Major Extremity Trauma Research Consortium. Started Jun 2021; status: completed.
02
Drugs
tobramycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04597008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04597008.